CompletedNCT01961518

Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome

Studying Mucopolysaccharidosis type 4A

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Greenwood Genetic Center
Principal Investigator: Richard Curtis Rogers, MD
Greenwood Genetic Center
Enrollment: 17 enrolled
Eligibility: 18 years · All sexes
Timeline: 2013 – 2015

Study locations (1)

Greenwood Genetic Center, Greenville, South Carolina, United States

Collaborators

Shriners Hospitals for Children · BioMarin Pharmaceutical

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01961518 on ClinicalTrials.gov

Other trials for Mucopolysaccharidosis type 4A

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05845749
Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI
University of California, San Francisco

See all trials for Mucopolysaccharidosis type 4A →

← Back to all trials